NT5E and colorectal cancer: The exploratory analysis of baseline tumor samples, which evaluates CD73 expression in relation to the best overall response, suggests that elevated CD73 expression may be associated with clinical benefits in microsatellite-stable colorectal cancer and PDAC [330].